IL85476A - Sustained release polysaccharide bound compositions for parenteral administration and their use in animals - Google Patents

Sustained release polysaccharide bound compositions for parenteral administration and their use in animals

Info

Publication number
IL85476A
IL85476A IL85476A IL8547688A IL85476A IL 85476 A IL85476 A IL 85476A IL 85476 A IL85476 A IL 85476A IL 8547688 A IL8547688 A IL 8547688A IL 85476 A IL85476 A IL 85476A
Authority
IL
Israel
Prior art keywords
animals
sustained release
parenteral administration
biologically active
increasing
Prior art date
Application number
IL85476A
Other languages
English (en)
Other versions
IL85476A0 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL85476A0 publication Critical patent/IL85476A0/xx
Publication of IL85476A publication Critical patent/IL85476A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y10S530/814—Cellulose or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL85476A 1987-03-09 1988-02-19 Sustained release polysaccharide bound compositions for parenteral administration and their use in animals IL85476A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/023,427 US4857505A (en) 1987-03-09 1987-03-09 Sustained release compositions for parenteral administration and their use

Publications (2)

Publication Number Publication Date
IL85476A0 IL85476A0 (en) 1988-07-31
IL85476A true IL85476A (en) 1991-08-16

Family

ID=21815030

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85476A IL85476A (en) 1987-03-09 1988-02-19 Sustained release polysaccharide bound compositions for parenteral administration and their use in animals

Country Status (14)

Country Link
US (1) US4857505A (de)
EP (1) EP0281809B1 (de)
JP (1) JPS63253030A (de)
AT (1) ATE92329T1 (de)
AU (1) AU603189B2 (de)
CA (1) CA1318249C (de)
DE (1) DE3882748D1 (de)
DK (1) DK124288A (de)
FI (1) FI881061A (de)
GR (1) GR3009565T3 (de)
HU (1) HU201681B (de)
IL (1) IL85476A (de)
NZ (1) NZ223715A (de)
ZA (1) ZA881657B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336506A (en) * 1986-07-03 1994-08-09 Advanced Magnetics Inc. Targeting of therapeutic agents using polysaccharides
US4929670A (en) * 1987-10-26 1990-05-29 National Starch And Chemical Investment Holding Corporation Polysaccharides containing aromatic aldehydes and their derivatization via amine-aldehyde interactions
US5011918A (en) * 1987-10-26 1991-04-30 National Starch And Chemical Investment Holding Corporation Polysaccharides containing aromatic aldehydes and their derivatization via amine-aldehyde interactions
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5637566A (en) * 1988-08-24 1997-06-10 Southern Cross Biotech Pty. Ltd. Method of improving carcass quality by administering growth hormone
US5174998A (en) * 1988-11-30 1992-12-29 Nisshin Flour Milling Co., Ltd. Sustained release compositions using as matrix hemicellulose extracted from wheat bran
US5032401A (en) * 1989-06-15 1991-07-16 Alpha Beta Technology Glucan drug delivery system and adjuvant
US5374620A (en) * 1990-06-07 1994-12-20 Genentech, Inc. Growth-promoting composition and its use
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
US5733891A (en) * 1990-10-18 1998-03-31 Shiseido Co., Ltd. Compound for medicinal ingredient and hyaluronic acid and process for producing the same
DE69125595T2 (de) * 1990-10-18 1997-11-13 Shiseido Co. Ltd., Tokio/Tokyo Kombination von hyaluronsäure mit einem medizinischen bestandteil, und seine herstellung
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
EP0563249B1 (de) * 1990-12-19 1997-04-23 Advanced Magnetics Incorporated Targeting von therapeutischen mitteln durch verwendung von polysacchariden
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US6284727B1 (en) * 1993-04-07 2001-09-04 Scios, Inc. Prolonged delivery of peptides
US5614487A (en) * 1993-05-28 1997-03-25 Genentech, Inc. Sustained release pharmaceutical composition
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
ATE386501T1 (de) * 1999-07-12 2008-03-15 Sandoz Ag Formulierungen von wachstumshormonen
CN1095472C (zh) 2000-04-17 2002-12-04 上海复康医药科技发展有限公司 叶酸－多聚糖复合物，其制备方法和以该复合物为活性成分的药物组合物
CN102180944A (zh) * 2001-10-10 2011-09-14 诺和诺德公司 肽的重构和糖缀合
MXPA05000413A (es) * 2002-07-09 2005-07-22 Sandoz Ag Formulaciones liquidas con una alta concentracion de hormona de crecimiento humana (hgh) que comprenden 1,2-propilenglicol.
CN113398273B (zh) * 2021-05-14 2022-07-19 广西壮族自治区中国科学院广西植物研究所 木聚糖衍生物作为亲水性缓释材料在制备药物缓释片中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH514650A (fr) * 1967-05-23 1971-10-31 Pharmacia Ab Procédé de préparation de dérivés de peptides insolubles dans l'eau
US4003792A (en) * 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
US3947352A (en) * 1974-05-31 1976-03-30 Pedro Cuatrecasas Polysaccharide matrices for use as adsorbents in affinity chromatography techniques
CA1167403A (en) * 1979-07-10 1984-05-15 Unilever Limited Microbial heteropolysaccharide
EP0085036A1 (de) * 1982-01-18 1983-08-03 Monsanto Company Verfahren zur Verbesserung der Rindermilchproduktion
US4521409A (en) * 1983-10-03 1985-06-04 Cornell Research Foundation, Inc. Use of growth hormone to enhance ruminant mammary development
US4585754A (en) * 1984-01-09 1986-04-29 Valcor Scientific, Ltd. Stabilization of proteins and peptides by chemical binding with chondroitin
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
EP0193917A3 (de) * 1985-03-06 1987-09-23 American Cyanamid Company Wasserdispersible und wasserlösliche Polymerzusammensetzungen für parenterale Anwendung
AU6073386A (en) * 1985-07-30 1987-02-05 International Minerals & Chemical Corporation Stabilization of growth promoting hormones
CA1285874C (en) * 1985-08-23 1991-07-09 Thomas Harry Ferguson Injectable sustained release formulation
EP0257368B1 (de) * 1986-08-11 1992-03-25 American Cyanamid Company Zusammensetzungen zur parenteralen Verabreichung und deren Verwendung

Also Published As

Publication number Publication date
IL85476A0 (en) 1988-07-31
EP0281809A3 (en) 1990-06-06
DK124288D0 (da) 1988-03-08
CA1318249C (en) 1993-05-25
FI881061A (fi) 1988-09-10
DK124288A (da) 1988-09-10
AU603189B2 (en) 1990-11-08
EP0281809B1 (de) 1993-08-04
FI881061A0 (fi) 1988-03-08
AU1277688A (en) 1988-09-08
ATE92329T1 (de) 1993-08-15
HU201681B (en) 1990-12-28
HUT47220A (en) 1989-02-28
DE3882748D1 (de) 1993-09-09
NZ223715A (en) 1990-11-27
US4857505A (en) 1989-08-15
EP0281809A2 (de) 1988-09-14
JPS63253030A (ja) 1988-10-20
GR3009565T3 (de) 1994-02-28
ZA881657B (en) 1988-09-06

Similar Documents

Publication Publication Date Title
IL85476A (en) Sustained release polysaccharide bound compositions for parenteral administration and their use in animals
AU1017088A (en) Sustained release growth hormone compositions for parenteral administration and their use
ES8704347A1 (es) Procedimiento de obtencion de composiciones a base de polimeros de carbohidratos solubles y dispersables en agua
ES2007414A6 (es) Procedimiento de produccion de productos naturales antioxidantes para fines mediocos.
ATE277638T1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
BG104141A (bg) Лечебни и хранителни състави, съдържащи незаменими мастни киселини и биоактивни дисулфиди
AU6020186A (en) Process for production of dry bioactive recombinant growth hormones
ES8606407A1 (es) Un procedimiento para preparar conjugados de galactosil-insulina
EP0308197A3 (de) Verfahren zur Stimulierung des Immunsystems
ES2012128A6 (es) Metodo de tratar plantas con acidos organicos que contienen azufre.
GR3004303T3 (de)
MD277C2 (ro) Preparat microbicid
ATE84194T1 (de) Vitamin u und verfahren zur behandlung von tieren mit vitamin u.
Ahemed et al. A study on changes in blood chemistry in parthenium toxicity in buffalo calves.
SU1823179A1 (ru) Способ подготовки сосудистых ксенопротезов сосудов и клапанов сердца к трансплантации
IT1209053B (it) Materiale conglomerabile per la realizzazione di manufatti erelativo procedimento diformazione.
HUT57689A (en) Process for increasing yields in plant cultivation and for improving the quality of crop
IT1209499B (it) Metodo per la somministrazione enterale o parenterale di soluzioni o sospensioni.
MD409G2 (ro) Metodă de tratament al colibacilozei la viţei
RU96108586A (ru) Способ приготовления премикса
KR890007660A (ko) 관상어용 사료의 유산균 배양 제조방법
RU96103722A (ru) Способ лечения компрессионно-ишемической невропатии
SU1471341A1 (ru) Состав для регулирования роста облепихи